Company Search:
Advanced Search
Sponsored Links
Karo Pharma AB Company Snapshot
Karo Pharma AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Karo Pharma AB with three other miscellaneous service companies in Europe: Ablynx N.V. of Belgium (2017 sales of 55.53 million Euro [US$68.22 million] ), Basilea Pharmaceutica Limited of Switzerland (90.67 million Swiss Francs [US$95.25 million] of which 100% was Pharmaceutical Products), and MorphoSys AG which is based in Germany (66.79 million Euro [US$82.05 million] of which 74% was Partnered Discovery).

Sales Analysis. During the year ended December of 2017, sales at Karo Pharma AB were SEK 657.61 million (US$80.27 million). This is an increase of 89.4% versus 2016, when the company's sales were SEK 347.26 million. This was the third consecutive year of growth at Karo Pharma AB.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Karo Pharma AB
  Stock Performance Chart for Karo Pharma AB
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 32.80
(Figures in Swedish Kronor)
1 Week -8.6%   13 Weeks -4.0%  
4 Weeks -3.5%   52 Weeks 9.4%  
Karo Pharma AB Key Data:
  Ticker: KARO Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 657,606,000
(Year Ending Jan 2018).
Employees: 69
  Currency: Swedish Kronor Market Cap: 2,849,047,206
  Fiscal Yr Ends: December Shares Outstanding: 86,861,195
  Share Type: Fri Aktie Closely Held Shares: 22,781,455
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.